PROTEO INC
company.status.inactiveCIK 1063104fmd_0XH9W4CK4T6HR7TY6H0M2XKJKFManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2001 to Mar 31, 2020, 49 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Net interest income | 0 | 0 | – | – | – | – | – | – | – | – |
| Research and development | – | – | – | – | – | 1 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 |
| Total operating expenses | – | – | – | – | – | 1 | 0 | 0 | 0 | 0 |
| Operating income | – | – | – | – | – | (0) | (0) | (0) | (0) | (0) |
| Other non-operating income (expense) | – | 0 | 0 | (0) | 0 | 0 | 0 | (0) | 0 | 0 |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | (1) | (1) | (1) | (1) | (0) | (0) | (0) | (0) | 0 | (0) |
| Net income to common shareholders | (1) | (1) | (1) | (1) | (0) | (0) | – | – | – | – |